{"protocolSection": {"identificationModule": {"nctId": "NCT00146848", "orgStudyIdInfo": {"id": "CR-CA-100604-H"}, "secondaryIdInfos": [{"id": "PEGASUS"}], "organization": {"fullName": "Boston Scientific Corporation", "class": "INDUSTRY"}, "briefTitle": "PEGASUS CRT Study: Atrial Support Study in Cardiac Resynchronization Therapy", "officialTitle": "Pacing Evaluation - Atrial Support Study in Cardiac Resynchronization Therapy", "acronym": "PEGASUS CRT"}, "statusModule": {"statusVerifiedDate": "2011-12", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2004-12"}, "primaryCompletionDateStruct": {"date": "2009-01", "type": "ACTUAL"}, "completionDateStruct": {"date": "2009-02", "type": "ACTUAL"}, "studyFirstSubmitDate": "2005-09-02", "studyFirstSubmitQcDate": "2005-09-06", "studyFirstPostDateStruct": {"date": "2005-09-07", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2010-02-28", "resultsFirstSubmitQcDate": "2010-09-21", "resultsFirstPostDateStruct": {"date": "2010-09-23", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2011-12-20", "lastUpdatePostDateStruct": {"date": "2011-12-28", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Boston Scientific Corporation", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "This study will look at different pacing modes (how a device is programmed to pace one's heart), and how these modes may assist in one's daily activities and how one is feeling.", "detailedDescription": "PEGASUS CRT is a multicenter trial that will assess the effect of a cardiac resynchronization therapy defibrillator (CRT-D) device programmed to DDD-70 or DDDR-40 compared to a CRT device programmed to DDD-40 in heart failure patients. The effect of atrial support pacing in heart failure patients will be assessed using a clinical composite rating. A sub-study will evaluate the effect pacing mode has on exercise capacity in this heart failure population."}, "conditionsModule": {"conditions": ["Heart Failure"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE4"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "SINGLE", "whoMasked": ["PARTICIPANT"]}}, "enrollmentInfo": {"count": 1742, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "DDD-40", "type": "ACTIVE_COMPARATOR", "description": "DDD-40 for this trial is the comparator arm. Even though patients are receiving a CRT-D device, atrial support pacing in this arm will be limited as the device will not pace unless the rate falls below 40 bpm.", "interventionNames": ["Device: Atrial support pacing through cardiac resynchronization therapy. Device: RENEWAL family of CRT-D devices"]}, {"label": "DDDR-40", "type": "ACTIVE_COMPARATOR", "description": "DDDR-40 programming will initiate atrial support pacing if the rate falls below 40 bpm or if atrial support is needed in response to increased activity.", "interventionNames": ["Device: Atrial support pacing through cardiac resynchronization therapy. Device: RENEWAL family of CRT-D devices"]}, {"label": "DDD-70", "type": "ACTIVE_COMPARATOR", "description": "Atrial support pacing in this arm will be delivered when the rate falls below 70 bpm.", "interventionNames": ["Device: Atrial support pacing through cardiac resynchronization therapy. Device: RENEWAL family of CRT-D devices"]}], "interventions": [{"type": "DEVICE", "name": "Atrial support pacing through cardiac resynchronization therapy. Device: RENEWAL family of CRT-D devices", "description": "All subjects in this trial receive the same device. For the purpose of this trial, \"intervention\" is programming mode and lower rate limit to deliver atrial support pacing in the two treatment arms, while the control arm will receive programming where limited atrial support pacing is delivered. DDD-70 and DDDR-40 are the treatment arms programmed to receive atrial support pacing and will be compared to the DDD-40 arm.", "armGroupLabels": ["DDD-40", "DDD-70", "DDDR-40"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Clinical Composite Score", "description": "The primary outcome measure classified patients as improved, unchanged or worsened, based on a 4 components clinical composite score using the following four components: death, heart failure hospitalization, New York Heart Association \\[NYHA\\] class, patient's Global Assessment rating. Best value is improved, whereas worst value is worsened.", "timeFrame": "From randomization (6-weeks) through 12-month visit"}], "secondaryOutcomes": [{"measure": "Change in Quality of Life", "description": "Quality of Life as assessed by the Minnesota Living with Heart Failure Questionniare for those patients with paired data at 6 weeks and 12 months. This score is on a scale of 0(best)- 105(worst). A negative change denotes improvement.", "timeFrame": "From randomization (6-weeks) through 12-month visit"}, {"measure": "Change in Self Assessed Physical Activity", "description": "Physical activity was assessed using the Physical Activity Scale of the Elderly (PASE) questionnaire for those patients with paired data available at the 6 week and 12 month visits. The PASE is designed to assess physical activity in older persons. The total PASE score was computed by multiplying the amount of time spent in each activity (hours/week) or participation (yes/no) in an activity by empirically derived item weights and summing over all activities. PASE scores for this study ranged from 0 to 756 with higher scores indicating more physical activity.", "timeFrame": "From randomization (6-weeks) through 12-month visit"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Patients who meet current indications for the CONTAK RENEWAL\u00ae family of cardiac resynchronization therapy defibrillator (CRT-D) devices or future Food and Drug Administration (FDA) approved Guidant CRT-D devices\n* Patients who sign and date a Patient Informed Consent at, or prior to, the implant visit\n* Patients who are in sinus rhythm at the time of implant\n* Patients who remain in the clinical care of the enrolling physician in approved centers\n* Patients who are on optimal pharmacologic therapy or who have developed a recent implantable cardioverter defibrillator (ICD) indication that necessitates ICD therapy concurrent with the optimization of pharmacologic therapy\n\nExclusion Criteria:\n\n* Patients whose medical condition is expected to preclude the use of the protocol-required pacing mode (dual chamber pacing \\[DDD or DDDR\\]) and respective lower rate limits\n* Patients with permanent atrial fibrillation or atrial flutter\n* Patients who are in complete heart block\n* Patients who have previously had a pacemaker, ICD, or CRT device\n* Patients whose life expectancy is less than 12 months due to other medical conditions\n* Patients who are expected to receive a heart transplant during the duration of the study\n* Patients who have other cardiac surgeries or procedures planned but not yet performed\n* Patients who currently have or who are likely to receive a tricuspid valve prosthesis\n* Patients who are currently enrolled in another investigational study or registry that would directly impact the treatment or outcome of the current study.\n* Patients who are younger than 18 years of age\n* Patients who are mentally incompetent and cannot sign a Patient Informed Consent form or comply with the study\n* Patients who are or become pregnant", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "David O. Martin, MD, MPH", "affiliation": "The Cleveland Clinic", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "John Day", "affiliation": "Utah Heart Clinic, LDS Hospital", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "The Cleveland Clinic Hospital", "city": "Cleveland", "state": "Ohio", "zip": "44195", "country": "United States", "geoPoint": {"lat": 41.4995, "lon": -81.69541}}]}, "referencesModule": {"references": [{"pmid": "17174627", "type": "BACKGROUND", "citation": "Martin DO, Stolen KQ, Brown S, Yu Y, Christie C, Doshi SK, Smith JM, Gold MR, Day JD. Pacing Evaluation-Atrial SUpport Study in Cardiac Resynchronization Therapy (PEGASUS CRT): design and rationale. Am Heart J. 2007 Jan;153(1):7-13. doi: 10.1016/j.ahj.2006.10.013."}, {"pmid": "22830441", "type": "DERIVED", "citation": "Martin DO, Day JD, Lai PY, Murphy AL, Nayak HM, Villareal RP, Weiner S, Kraus SM, Stolen KQ, Gold MR. Atrial support pacing in heart failure: results from the multicenter PEGASUS CRT trial. J Cardiovasc Electrophysiol. 2012 Dec;23(12):1317-25. doi: 10.1111/j.1540-8167.2012.02402.x. Epub 2012 Jul 25."}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "All patients with successful system implants were programmed to DDD-40 (atrial rate support above 40 bpm; limited atrial pacing) for the first 6-weeks of the trial. Randomization (1:1:1 allocation) occurred after patients had reached the 6-week visit and continued to meet all of the eligibility criteria for the trial.", "recruitmentDetails": "Enrollment began on November 8, 2004, was completed on December 21, 2007, with study follow-up commencing January 30, 2009. This trial was conducted at institutional settings throughout the United States and Australia.", "groups": [{"id": "FG000", "title": "DDD-40", "description": "Atrial Tracking (atrial rate support above 40 bpm)"}, {"id": "FG001", "title": "DDD-70", "description": "Atrial Rate Support (atrial rate support above 70 bpm)"}, {"id": "FG002", "title": "DDDR-40", "description": "Rate Adaptive Pacing (atrial rate support above 40 bpm with rate responsive pacing)"}], "periods": [{"title": "Pre-randomization", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "comment": "Registered", "numSubjects": "1742"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "comment": "Reached 6-week visit and were randomized", "numSubjects": "1433"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "309"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}]}], "dropWithdraws": [{"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "19"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "70"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}]}, {"type": "Physician Decision", "reasons": [{"groupId": "FG000", "numSubjects": "8"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}]}, {"type": "Protocol Violation", "reasons": [{"groupId": "FG000", "numSubjects": "172"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "40"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}]}]}, {"title": "Post-randomization", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "475"}, {"groupId": "FG001", "numSubjects": "488"}, {"groupId": "FG002", "numSubjects": "470"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "437"}, {"groupId": "FG001", "numSubjects": "441"}, {"groupId": "FG002", "numSubjects": "431"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "38"}, {"groupId": "FG001", "numSubjects": "47"}, {"groupId": "FG002", "numSubjects": "39"}]}], "dropWithdraws": [{"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "12"}, {"groupId": "FG001", "numSubjects": "15"}, {"groupId": "FG002", "numSubjects": "12"}]}, {"type": "Withdrawn", "reasons": [{"groupId": "FG000", "numSubjects": "26"}, {"groupId": "FG001", "numSubjects": "32"}, {"groupId": "FG002", "numSubjects": "27"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "DDD-40", "description": "Atrial Tracking (atrial rate support above 40 bpm)"}, {"id": "BG001", "title": "DDD-70", "description": "Atrial Rate Support (atrial rate support above 70 bpm)"}, {"id": "BG002", "title": "DDDR-40", "description": "Rate Adaptive Pacing (atrial rate support above 40 bpm with rate responsive pacing)"}, {"id": "BG003", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "475"}, {"groupId": "BG001", "value": "488"}, {"groupId": "BG002", "value": "470"}, {"groupId": "BG003", "value": "1433"}]}], "measures": [{"title": "Age Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "67.3", "spread": "11.4"}, {"groupId": "BG001", "value": "67.5", "spread": "10.4"}, {"groupId": "BG002", "value": "66.7", "spread": "11.6"}, {"groupId": "BG003", "value": "67.2", "spread": "11.1"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "165"}, {"groupId": "BG001", "value": "156"}, {"groupId": "BG002", "value": "165"}, {"groupId": "BG003", "value": "486"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "310"}, {"groupId": "BG001", "value": "332"}, {"groupId": "BG002", "value": "305"}, {"groupId": "BG003", "value": "947"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "SECONDARY", "title": "Change in Quality of Life", "description": "Quality of Life as assessed by the Minnesota Living with Heart Failure Questionniare for those patients with paired data at 6 weeks and 12 months. This score is on a scale of 0(best)- 105(worst). A negative change denotes improvement.", "populationDescription": "Quality of Life was analyzed for those patients with paired data available at the 6 week and 12 month visit. Patients were analyzed in their randomized groups.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "units on a scale", "timeFrame": "From randomization (6-weeks) through 12-month visit", "groups": [{"id": "OG000", "title": "DDD-40", "description": "Atrial Tracking (atrial rate support above 40 bpm)"}, {"id": "OG001", "title": "DDD-70", "description": "Atrial Rate Support (atrial rate support above 70 bpm)"}, {"id": "OG002", "title": "DDDR-40", "description": "Rate Adaptive Pacing (atrial rate support above 40 bpm with rate responsive pacing)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "348"}, {"groupId": "OG001", "value": "370"}, {"groupId": "OG002", "value": "357"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-2.97", "spread": "24.18"}, {"groupId": "OG001", "value": "-3.27", "spread": "22.77"}, {"groupId": "OG002", "value": "-4.46", "spread": "25.43"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "The changes in quality of life were compared between groups using two-sided t-tests.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.86", "statisticalMethod": "t-test, 2 sided", "paramType": "Mean Difference (Final Values)", "paramValue": "0.30", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-3.14", "ciUpperLimit": "3.74", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "1.75"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "The difference in changes in quality of life between groups were compared using a t-test.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.43", "statisticalMethod": "t-test, 2 sided", "paramType": "Mean Difference (Final Values)", "paramValue": "1.49", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-2.18", "ciUpperLimit": "5.16", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "1.87"}]}, {"type": "PRIMARY", "title": "Clinical Composite Score", "description": "The primary outcome measure classified patients as improved, unchanged or worsened, based on a 4 components clinical composite score using the following four components: death, heart failure hospitalization, New York Heart Association \\[NYHA\\] class, patient's Global Assessment rating. Best value is improved, whereas worst value is worsened.", "populationDescription": "This analysis is intention to treat (ITT) in terms of patient's being analyzed according to their randomized group. Last observation carried forward (LOCF) method was used for missing NYHA and global assessment measures at 12 months.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "From randomization (6-weeks) through 12-month visit", "groups": [{"id": "OG000", "title": "DDD-40", "description": "Atrial Tracking (atrial rate support above 40 bpm)"}, {"id": "OG001", "title": "DDD-70", "description": "Atrial Rate Support (atrial rate support above 70 bpm)"}, {"id": "OG002", "title": "DDDR-40", "description": "Rate Adaptive Pacing (atrial rate support above 40 bpm with rate responsive pacing)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "437"}, {"groupId": "OG001", "value": "441"}, {"groupId": "OG002", "value": "431"}]}], "classes": [{"title": "Improved", "categories": [{"measurements": [{"groupId": "OG000", "value": "230"}, {"groupId": "OG001", "value": "235"}, {"groupId": "OG002", "value": "229"}]}]}, {"title": "Unchanged", "categories": [{"measurements": [{"groupId": "OG000", "value": "84"}, {"groupId": "OG001", "value": "94"}, {"groupId": "OG002", "value": "85"}]}]}, {"title": "Worsened", "categories": [{"measurements": [{"groupId": "OG000", "value": "123"}, {"groupId": "OG001", "value": "112"}, {"groupId": "OG002", "value": "117"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "One sided test testing for shift towards improvement in either atrial support pacing treatment arm compared to the DDD-40 arm.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.55", "statisticalMethod": "Cochran-Armitage test for trend", "ciPctValue": "95"}, {"groupIds": ["OG000", "OG002"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.80", "statisticalMethod": "Cochran-Armitage test for trend", "ciPctValue": "95"}]}, {"type": "SECONDARY", "title": "Change in Self Assessed Physical Activity", "description": "Physical activity was assessed using the Physical Activity Scale of the Elderly (PASE) questionnaire for those patients with paired data available at the 6 week and 12 month visits. The PASE is designed to assess physical activity in older persons. The total PASE score was computed by multiplying the amount of time spent in each activity (hours/week) or participation (yes/no) in an activity by empirically derived item weights and summing over all activities. PASE scores for this study ranged from 0 to 756 with higher scores indicating more physical activity.", "populationDescription": "Physical activity was assessed using the Physical Activity Scale for the Elderly and was analyzed for those patients with paired data available at the 6 week and 12 month visit. Patients were analyzed in their randomized groups. Postive values for changes denote improvements.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "units on a scale", "timeFrame": "From randomization (6-weeks) through 12-month visit", "groups": [{"id": "OG000", "title": "DDD-40", "description": "Atrial Tracking (atrial rate support above 40 bpm)"}, {"id": "OG001", "title": "DDD-70", "description": "Atrial Rate Support (atrial rate support above 70 bpm)"}, {"id": "OG002", "title": "DDDR-40", "description": "Rate Adaptive Pacing (atrial rate support above 40 bpm with rate responsive pacing)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "339"}, {"groupId": "OG001", "value": "362"}, {"groupId": "OG002", "value": "348"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "12.45", "spread": "78.62"}, {"groupId": "OG001", "value": "22.62", "spread": "88.86"}, {"groupId": "OG002", "value": "25.69", "spread": "92.41"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Compare the difference in the changes in physical activity scores between groups using a t-test.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.11", "statisticalMethod": "t-test, 2 sided", "paramType": "Mean Difference (Final Values)", "paramValue": "-10.17", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-22.65", "ciUpperLimit": "2.30", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "6.35"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Compare the difference in the changes in physical activity scores between groups using a t-test.\n\nTo adjust for multiple comparisons, an alpha level of 0.025 should be used to deem significance.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.04", "statisticalMethod": "t-test, 2 sided", "paramType": "Mean Difference (Final Values)", "paramValue": "-13.24", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-26.11", "ciUpperLimit": "-0.37", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "6.55"}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "Adverse event data were collected from randomization (6-weeks) through the 12-month follow-up visit. Per trial design, serious adverse events were not collected in this trial.", "description": "Source vocabulary for AE coding was not used in this trial. Serious adverse events were not collected in this trial per trial design.", "eventGroups": [{"id": "EG000", "title": "DDD-40", "description": "Atrial Tracking (atrial rate support above 40 bpm)", "seriousNumAffected": 0, "seriousNumAtRisk": 0, "otherNumAffected": 129, "otherNumAtRisk": 475}, {"id": "EG001", "title": "DDD-70", "description": "Atrial Rate Support (atrial rate support above 70 bpm)", "seriousNumAffected": 0, "seriousNumAtRisk": 0, "otherNumAffected": 119, "otherNumAtRisk": 488}, {"id": "EG002", "title": "DDDR-40", "description": "Rate Adaptive Pacing (atrial rate support above 40 bpm with rate responsive pacing)", "seriousNumAffected": 0, "seriousNumAtRisk": 0, "otherNumAffected": 112, "otherNumAtRisk": 470}], "otherEvents": [{"term": "Cardiovascular related", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 124, "numAffected": 80, "numAtRisk": 475}, {"groupId": "EG001", "numEvents": 125, "numAffected": 89, "numAtRisk": 488}, {"groupId": "EG002", "numEvents": 117, "numAffected": 76, "numAtRisk": 470}]}, {"term": "Non-device, non-lead, non-procedure or non-cardiovascular related AE \"other\"", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 82, "numAffected": 64, "numAtRisk": 475}, {"groupId": "EG001", "numEvents": 58, "numAffected": 43, "numAtRisk": 488}, {"groupId": "EG002", "numEvents": 54, "numAffected": 45, "numAtRisk": 470}]}]}, "moreInfoModule": {"limitationsAndCaveats": {"description": "Lack of longer-term follow-up. Single blind design where investigator could be aware of treatment assignment. Two conservative atrial support pacing modes; results should not be extended to substantially more atrial pacing and higher heart rates."}, "certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 30 days from the time submitted to the sponsor for review."}, "pointOfContact": {"title": "Kira Stolen", "organization": "Clinical Affairs", "email": "cshd@bsci.com", "phone": "1 800 CARDIAC"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}